Thermosensitive Nanocarrier for Pulse Drug Release in Cancer Therapy - Kundu, Moumita
42,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
21 °P sammeln
  • Broschiertes Buch

Cancer is the second deadly disease worldwide. According to the report of WHO, it causes 8.8 million deaths in 2015 globally. Moreover, limited numbers of options are available for cancer treatment in developing countries as efficient applications are not possible in all cases. Therefore smart delivery systems are required to develop for effective cancer therapy. Two points are very crucial for successful cancer therapy: i) improvement of drug's efficacy and ii) low cytotoxicity on normal cells. In this book, smart nanocarrier has been developed for the purpose of paclitaxel release in…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cancer is the second deadly disease worldwide. According to the report of WHO, it causes 8.8 million deaths in 2015 globally. Moreover, limited numbers of options are available for cancer treatment in developing countries as efficient applications are not possible in all cases. Therefore smart delivery systems are required to develop for effective cancer therapy. Two points are very crucial for successful cancer therapy: i) improvement of drug's efficacy and ii) low cytotoxicity on normal cells. In this book, smart nanocarrier has been developed for the purpose of paclitaxel release in response of temperature change during hyperthermia treatment. Higher temperature of hyperthermia synergistically improves the efficacy of paclitaxel and using local hyperthermia its toxic effects on normal cells can be reduced.
Autorenporträt
Moumita Kundu acquired B.Pharm and M.Pharm from Jadavpur University, India in 2013 and 2015 respectively. She achieved University Gold Medal for standing 1st in order of merit at the B.Pharm examination, 2013. Presently, she is a research scholar in SMST, IITKGP, India. Her research is focused on glioma treatment.